Beijing Huareidingxin Technology

Beijing Huareidingxin Technology is a high-tech medical device company headquartered in Beijing, China, dedicated to the research, development, and commercialization of interventional treatments for structural heart disease. The company's core product portfolio includes advanced transcatheter aortic valve replacement (TAVR) systems and mitral valve repair technologies designed for minimally invasive cardiac surgery. By leveraging proprietary engineering and clinical insights, Huareidingxin aims to provide effective and accessible solutions for patients suffering from valvular heart diseases. The company is backed by prominent venture capital firms and maintains a strong focus on the domestic Chinese cardiovascular market.